CloudMe.com web user interface
CloudMe and Globell launch a secure joint European Cloud for the German speaking market
June 07, 2017 08:58 ET | Xcerion AB
Linköping/Tegelen, EU, June 07, 2017 (GLOBE NEWSWIRE) -- CloudMe, Europe’s leading provider of cloud sync and storage, with over 1.5 million subscribers, and Globell, the software distributor...
Kanguru-GDPR-Whitepaper-and-infographic-globe
Kanguru: Why Non-EU Organizations Can’t Afford To Ignore GDPR
May 31, 2017 07:00 ET | Kanguru Solutions
MILLIS, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- One of the biggest changes in data security regulations is coming out of the European Union that will have a significant impact on organizations...
BioAffinity.jpg
bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET | bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
Institutional Invest
Institutional Investors Facing Difficult Challenge as Passive Investing, Unbundling, and Cost Pressures Threaten Their Very Existence According To TABB Group’s Latest Research - US Institutional Equity Trading 2017: In the Eye of the Storm
April 17, 2017 10:30 ET | TABB Group
NEW YORK and LONDON, April 17, 2017 (GLOBE NEWSWIRE) -- The reallocation of assets from active, fundamentally-based investment strategies to passive/ETF index-based products has the industry on...
XOMA royalty-2c.png
XOMA Reports Second Quarter 2016 Achievements and Financial Results
August 03, 2016 16:01 ET | XOMA Corporation
BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and...
XOMA royalty-2c.png
XOMA Receives Orphan Drug Designation in the European Union for XOMA 358 for Treatment of Congenital Hyperinsulinism
July 20, 2016 09:00 ET | XOMA Corporation
XOMA 358 previously secured Orphan Drug Designation from the FDA for the treatment of Congenital Hyperinsulinism (CHI)Phase 2 clinical studies currently enrolling patients with CHI in the United...
Apigee Announces New
Apigee Announces New Open Banking Solution for PSD2
May 19, 2016 03:00 ET | Apigee
LONDON, May 19, 2016 (GLOBE NEWSWIRE) -- OPEN BANKING & PSD2 SUMMIT — Apigee® (NASDAQ:APIC), developer of a leading API platform, today announced Apigee Open Banking APIx, a new software...
WebMoney Gets a Euro
WebMoney Gets a European License and is Expanding Its Presence in the European Union
November 17, 2015 05:00 ET | WebMoney
LONDON, Nov. 17, 2015 (GLOBE NEWSWIRE) -- The FCA (Financial Conduct Authority) license granted to WebMoney Europe Ltd with head offices in Cambridge, United Kingdom has secured the company's status...
AIMLogo.jpg
Hemispherx Biopharma Europe N.V./S.A.: Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Ampligen/Rintatolimod for Ebola Virus Disease (EVD)
May 26, 2015 12:46 ET | AIM ImmunoTech Inc.
PHILADELPHIA, May 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that the European Medicines Agency (EMA) has published on May 22,...
RateRadarGraph-1
HSH.com Weekly Mortgage Rates Radar: Fixed Mortgage Rates Jump Back to December Levels
May 13, 2015 05:10 ET | QuinStreet
FOSTER CITY, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Rates on the most popular types of mortgages climbed again this week, according to HSH.com's Weekly Mortgage Rates Radar. The average rate for...